BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27405089)

  • 1. Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.
    Malina J; Hannon MJ; Brabec V
    Sci Rep; 2016 Jul; 6():29674. PubMed ID: 27405089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Element Interaction in HIV-1 TAR.
    Krawczyk K; Sim AY; Knapp B; Deane CM; Minary P
    J Chem Inf Model; 2016 Sep; 56(9):1746-54. PubMed ID: 27500460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo.
    Cardo L; Nawroth I; Cail PJ; McKeating JA; Hannon MJ
    Sci Rep; 2018 Sep; 8(1):13342. PubMed ID: 30190568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication.
    Wang D; Iera J; Baker H; Hogan P; Ptak R; Yang L; Hartman T; Buckheit RW; Desjardins A; Yang A; Legault P; Yedavalli V; Jeang KT; Appella DH
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6893-7. PubMed ID: 19896372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.
    Narayan V; Ravindra KC; Chiaro C; Cary D; Aggarwal BB; Henderson AJ; Prabhu KS
    J Mol Biol; 2011 Jul; 410(5):972-83. PubMed ID: 21763500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
    Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.
    Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW
    Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription.
    Mei HY; Mack DP; Galan AA; Halim NS; Heldsinger A; Loo JA; Moreland DW; Sannes-Lowery KA; Sharmeen L; Truong HN; Czarnik AW
    Bioorg Med Chem; 1997 Jun; 5(6):1173-84. PubMed ID: 9222511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
    Zhao H; Li J; Jiang L
    Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing protein-RNA interactions using microfluidic capillary mobility shift assays.
    Fourtounis J; Falgueyret JP; Sayegh CE
    Anal Biochem; 2011 Apr; 411(1):161-3. PubMed ID: 21130065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.
    Richter S; Ping YH; Rana TM
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7928-33. PubMed ID: 12048247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
    Agbottah ET; Traviss C; McArdle J; Karki S; St Laurent GC; Kumar A
    Retrovirology; 2007 Jun; 4():41. PubMed ID: 17565699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.